TNFRSF8 and diffuse large B-cell lymphoma: Ramos et al. reported the results of 9 patients with relapsed/refractory CD30+ lymphoma (6 with HL, 1 with cutaneous ALK negative ALCL, 1 with systemic ALK+ ALCL, and 1 with DLBCL evolved to HL) [32].